Understanding how the body fights Toxoplasma gondii infection

Role of reactive oxygen species in controlling T. gondii acute infection

NIH-funded research California State Poly U Pomona · NIH-11143732

This project explores how our immune cells, called neutrophils, use special chemicals to fight off the Toxoplasma gondii parasite, which can cause serious illness in some people.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCalifornia State Poly U Pomona NIH-funded
Lab location1 site (Pomona, United States)
Project IDNIH-11143732 on NIH RePORTER

What this research studies

Toxoplasma gondii is a common parasite that can lead to toxoplasmosis, a disease that is usually mild but can be life-threatening for those with weakened immune systems or unborn babies. Our bodies have immune cells called neutrophils that rush to the site of infection, but we don't fully understand how they work against this parasite. This project aims to discover the specific steps and signals that trigger neutrophils to produce 'reactive oxygen species' (ROS), which are chemicals that can kill the parasite. By learning which parts of the parasite neutrophils recognize and how they activate these killing chemicals, we hope to find new ways to help the body fight this infection.

Who could benefit from this research

Good fit: This foundational research is not directly recruiting patients but focuses on understanding a disease that affects individuals worldwide, especially those who are immunocompromised or pregnant.

Not a fit: Patients who do not have or are not at risk for Toxoplasma gondii infection would not directly benefit from this specific research.

Why it matters

Potential benefit: If successful, this work could lead to new treatments or vaccines for toxoplasmosis by enhancing the body's natural ability to fight the parasite.

How similar studies have performed: While it is known that neutrophils produce reactive oxygen species, the specific cellular and molecular mechanisms for how they kill Toxoplasma gondii are largely unknown, making this a novel area of focus.

Where this research is happening

Pomona, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acute Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.